82 lottery

NEW YORK, N.Y., Dec. 12, 2024 (SEND2PRESS NEWSWIRE) — HitPaw, a leading provider of innovative multimedia editing tools, is delivering the gift of creativity with its highly anticipated Christmas & New Year Sale. From Dec. 12, 2024 to Jan. 6, 2025, customers can enjoy up to 50% off on a wide range of HitPaw’s top-rated products, including video converter, photo enhancer, and AI-powered video enhancer and voice changer. WHAT’S INCLUDED IN THE HITPAW CHRISTMAS CAMPAIGN: EVENT HIGHLIGHTS: Special Gifts: Join activity to 100% win prize. You have the chance to win: iPhone 16 ($799 GoPro HERO($255) Netflix Premium Monthly Plan ($30) HitPaw Photo Object Remover – 1-Year Plan ($26.99) 30% OFF Discount Coupon 20% OFF Discount Coupon MASSIVE DISCOUNTS: Enjoy up to 30% off on best-selling tools like HitPaw VikPea, HitPaw Video Converter, and HitPaw FotorPea, available for a limited time only.Exclusive Christmas bundles are up to 50% off. The Buy One Get One option is perfect for those who are looking for the lowest price of HitPaw products. HERE IS THE LIST OF THE MAIN DISCOUNTS: HitPaw Video Converter at $41.97/Year for Windows & Mac HitPaw FotorPea at $62.99/Year for Windows & $69.99/Year for Mac HitPaw VikPea at $83.99/Year for Windows & $76.99/Year for Mac HitPaw Video Object Remover down to $0 HitPaw VoicePea at $27.97/Year for Windows & $32.17/Year for Mac 4-in-1 bundles: HitPaw VikPea +HitPaw FotorPea + HitPaw VoicePea +HitPaw Watermark Remover on $134.97 and $140.98 for Mac HOW TO PARTICIPATE: For more information or to participate in the event, visit: https://www.hitpaw.com/sales-promotion.html About HitPaw: HitPaw is a versatile software brand offering a suite of tools for video conversion, photo and video enhancement, and more. It provides user-friendly solutions designed for both beginners and professionals, enabling quick edits with high-quality output. HitPaw tools support a variety of creative needs, including video enhancement, format conversion, and meme creation, etc. Its intuitive interface and consistent updates make it a popular choice for content creators and everyday users. Don’t Miss Out — Grab Your Gift Today and Get Ready for an amazing Christmas! To know more, you may visit: https://www.hitpaw.com/about.html and https://www.hitpaw.com/ Our Social Media YouTube: https://www.youtube.com/channel/UCQwRggaotgiMcPbiCOsJeBA X/Twitter: https://x.com/HitPawofficial Instagram: https://www.instagram.com/hitpawofficial/ Pinterest: https://www.pinterest.com/hitpawcom/ NEWS SOURCE: HitPaw Keywords: Technology, hitpaw christmas sale, tech deals, holiday, softwae, apps, NEW YORK, N.Y. This press release was issued on behalf of the news source (HitPaw) who is solely responsibile for its accuracy, by Send2Press® Newswire . Information is believed accurate but not guaranteed. Story ID: S2P122798 APDF15TBLLI To view the original version, visit: https://www.send2press.com/wire/hitpaw-announces-exciting-christmas-sale-celebrate-the-season-with-unbeatable-discounts-and-special-gifts/ © 2024 Send2Press® Newswire, a press release distribution service, Calif., USA. Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.Cavaliers vs. Wizards Injury Report Today – December 13States and localities must move to protect workers should the Trump administration weaken federal laws that do so, former assistant labor secretary David Michaels writes in an opinion column. Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Most Popular Cause of underground fire at Williamsburg Premium Outlets still unknown — and may stay that way, fire chief says Cause of underground fire at Williamsburg Premium Outlets still unknown — and may stay that way, fire chief says Hampton’s superintendent just got a massive raise. Here’s how it compares. Hampton’s superintendent just got a massive raise. Here’s how it compares. Man taken into custody after shooting at Suffolk church staff member Man taken into custody after shooting at Suffolk church staff member Colonial Williamsburg’s Grand Illumination has echoes across the US Colonial Williamsburg's Grand Illumination has echoes across the US John Hinckley Jr. nixes plans to open Williamsburg music store John Hinckley Jr. nixes plans to open Williamsburg music store Disney influencer Dominique Brown dies at 34 after allergic reaction at food event, report says Disney influencer Dominique Brown dies at 34 after allergic reaction at food event, report says VHSL state semifinal scoreboard: Oscar Smith, Maury, Phoebus advance to championship games VHSL state semifinal scoreboard: Oscar Smith, Maury, Phoebus advance to championship games Williamsburg-area Democrats announce candidacy for House seats Williamsburg-area Democrats announce candidacy for House seats Hampton Roads native’s acting career grows with role on NBC’s ‘Brilliant Minds,’ airing Monday Hampton Roads native’s acting career grows with role on NBC’s ‘Brilliant Minds,’ airing Monday Hokies will play in Duke’s Mayo Bowl against Minnesota in Charlotte Hokies will play in Duke’s Mayo Bowl against Minnesota in Charlotte Trending Nationally Killing of UnitedHealthcare CEO spotlights complex challenge companies face in protecting top brass MAGA influencer Nick Fuentes charged with battery of woman he maced: report ‘America’s Got Talent’ comedian Kabir ‘Kabeezy’ Singh dead at 39 Police may search a vehicle based on the smell of raw cannabis, Illinois Supreme Court rules ‘Oppenheimer’ actor Emma Dumont comes out as transmasculine, changes name

ETSU 79, Austin Peay 57

Buggs' 15 lead East Tennessee State over Austin Peay 79-57

Ange Postecoglou relishing Tottenham’s key run of fixtures before ChristmasPITTSBURGH 74, LSU 63Test your 2024 knowledge from Olympic winners and political events to showbiz highlights and social media subs

LETTER: Sacrificing short-term rentals won't solve Victoria's housing crisis

NEW YORK , Dec. 12, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX ) pursuant and/or traceable to the Company's initial public offering conducted on February 8, 2024 (the "IPO"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 7, 2025 . So what: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 7, 2025 . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, the registration statement and prospectus used to effectuate Kyverna's IPO misstated and/or omitted facts concerning the results of Kyverna's ongoing evaluation of KYV-101, Kyverna's lead product candidate, in clinical trials. Specifically, Kyverna touted patient "improvement" in certain indicators while failing to disclose adverse data regarding one of Kyverna's trials, which adverse data was known to Kyverna at the time of the IPO. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com SOURCE THE ROSEN LAW FIRM, P. A.Houston Texans wide receiver Nico Collins scored a touchdown against the Tennessee Titans in his most recent home game and tossed the ball to a child in the stands pleading for it. On Thursday, Collins told reporters the NFL did not approve and assessed him a fine of about $5,000. "It's for the kids," Collins said. "I seen he was screaming and was thinking, ‘Here you go, big dog. Here's the ball.'" Collins said he was not penalized last season on the handful of occasions he threw a ball into the stands, so he wasn't expecting a fine. But making a child's day was "definitely worth it." The 25-year-old said he plans to appeal the fine, but if it isn't overturned, he'll pay up. "The only thing that matters was making that kid happy," he said. "He ain't never going to forget that moment. So that's all that matters to me." Collins followed up a 92-yard, one-touchdown performance that day against Tennessee with eight receptions for 119 yards last week at Jacksonville. The fourth-year wideout is Houston's leading receiver despite missing five games due to a hamstring injury. He has caught 49 passes for 832 yards and four touchdowns in just eight appearances. --Field Level Media

CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "Reflecting on 2024, Citius Oncology has achieved pivotal milestones that underscore our commitment to advancing cancer therapeutics," stated Leonard Mazur , Chairman and CEO of Citius Oncology. "The FDA's approval of LYMPHIR for the treatment of cutaneous T-cell lymphoma marks a significant advancement in providing new options for patients battling this challenging disease. It is the only targeted systemic therapy approved for CTCL patients since 2018 and the only therapy with a mechanism of action that targets the IL-2 receptor. Additionally, the successful merger forming Citius Oncology, now trading on Nasdaq under the ticker CTOR, strengthens our position in the oncology sector. We expect it to facilitate greater access to capital to fund LYMPHIR's launch and the Company's future growth. With a Phase I investigator-initiated clinical trial combining LYMPHIR with pembrolizumab demonstrating promising preliminary results, indicating potential for enhanced treatment efficacy in recurrent solid tumors, and preliminary results expected from a second investigator trial with CAR-T therapies in 2025, we remain excited about the potential of LYMPHIR as a combination immunotherapy." "These accomplishments reflect the dedication of our team and the trust of our investors. As we look ahead, we remain steadfast in our mission to develop innovative therapies that improve the lives of cancer patients worldwide," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Research and Development (R&D) Expenses R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 . The increase reflects development activities completed for the resubmission of the Biologics License Application of LYMPHIR in January 2024 , which were associated with the complete response letter remediation. General and Administrative (G&A) Expenses G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-commercial and commercial launch activities of LYMPHIR including market research, marketing, distribution and drug product reimbursement from health plans and payers. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $7.5 million as compared to $2.0 million for the prior year. The primary reason for the $5.5 million increase was due to the amounts being realized over 12 months in the year ended September 30, 2024 , as compared to three months post-plan adoption in the year ended September 30, 2023 . Net loss Net loss was $21.1 million , or ($0.31) per share for the year ended September 30, 2024 , compared to a net loss of $12.7 million , or ($0.19) per share for the year ended September 30, 2023 . The $8.5 million increase in net loss was primarily due to the increase in our operating expenses. About Citius Oncology, Inc. Citius Oncology specialty is a biopharmaceutical company focused on developing and commercializing novel targeted oncology therapies. In August 2024 , its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million , is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. For more information, please visit www.citiusonc.com Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Oncology are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; risks related to research using our assets but conducted by third parties; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS ONCOLOGY, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 Current Assets: Cash and cash equivalents $ 112 $ — Inventory 8,268,766 — Prepaid expenses 2,700,000 7,734,895 Total Current Assets 10,968,878 7,734,895 Other Assets: In-process research and development 73,400,000 40,000,000 Total Other Assets 73,400,000 40,000,000 Total Assets $ 84,368,878 $ 47,734,895 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,711,622 $ 1,289,045 License payable 28,400,000 — Accrued expenses — 259,071 Due to related party 588,806 19,499,119 Total Current Liabilities 32,700,429 21,047,235 Deferred tax liability 1,728,000 1,152,000 Note payable to related party 3,800,111 — Total Liabilities 38,228,540 22,199,235 Stockholders' Equity: Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding — — Common stock - $0.0001 par value; 100,000,000; 71,552,402 and 67,500,000 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,155 6,750 Additional paid-in capital 85,411,771 43,658,750 Accumulated deficit (39,278,587) (18,129,840) Total Stockholders' Equity 46,140,339 25,535,660 Total Liabilities and Stockholders' Equity $ 84,368,878 $ 47,734,895 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 4,925,001 4,240,451 General and administrative 8,148,929 5,915,290 Stock-based compensation – general and administrative 7,498,817 1,965,500 Total Operating Expenses 20,572,747 12,121,241 Loss before Income Taxes (20,572,747) (12,121,241) Income tax expense 576,000 576,000 Net Loss $ (21,148,747) $ (12,697,241) Net Loss Per Share – Basic and Diluted $ (0.31) $ (0.19) Weighted Average Common Shares Outstanding – Basic and Diluted 68,053,607 67,500,000 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Cash Flows From Operating Activities: Net loss $ (21,148,747) $ (12,697,241) Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense 7,498,817 1,965,500 Deferred income tax expense 576,000 576,000 Changes in operating assets and liabilities: Inventory (2,133,871) - Prepaid expenses (1,100,000) (5,044,713) Accounts payable 2,422,577 1,196,734 Accrued expenses (259,071) (801,754) Due to related party 14,270,648 14,805,474 Net Cash Provided By Operating Activities 126,353 - Cash Flows From Investing Activities: License payment (5,000,000) - Net Cash Used In Investing Activities (5,000,000) - Cash Flows From Financing Activities: Cash contributed by parent 3,827,944 - Merger, net (2,754,296) - Proceeds from issuance of note payable to related party 3,800,111 - Net Cash Provided By Financing Activities 4,873,759 - Net Change in Cash and Cash Equivalents 112 - Cash and Cash Equivalents – Beginning of Year - - Cash and Cash Equivalents – End of Year $ 112 $ - Supplemental Disclosures of Cash Flow Information and Non-cash Activities: IPR&D Milestones included in License Payable $ 28,400,000 $

DK Metcalf is happy to block as Seahawks ride streak into Sunday night matchup with PackersTo lure Juan Soto, Mets created a video of his statue outside Citi Field next to Tom Seaver'sPooches in pullovers strut their stuff at London's canine Christmas sweater parade( ) has been steadily making its mark as one of Canada’s prominent financial institutions. As we look toward 2025, the stock presents an intriguing blend of opportunity and caution. Known for its strong regional dominance, particularly in Quebec, and its ability to diversify income streams, National Bank stock is well-positioned to deliver solid shareholder . Let’s break down the key elements shaping its outlook as we move into the new year – from recent earnings to broader market sentiment. Into earnings In its most recent earnings report for the fourth quarter of 2024, National Bank posted a net income of $955 million. A remarkable 27% increase compared to the same period in 2023. Diluted earnings per share (EPS) came in at $2.66, up from $2.09. This exceeded analysts’ expectations and underscored the bank’s continued financial strength. This impressive growth was driven by exceptional performance in wealth management. This saw adjusted net income grow by 17% year-over-year to $219 million. Looking at the big picture, National Bank’s revenue for the trailing 12 months reached $10.6 billion, thus representing 19.7% year-over-year growth. The return on equity (ROE), a key metric that measures profitability against shareholder equity, stands at 15.2%, thereby affirming the bank’s effective use of its capital to drive returns. Notably, analysts project that the bank will maintain a strong ROE of 16.1% over the next three years. This is well above industry averages. Dividends and value One area where National Bank stock shines is its dividend performance. The bank offers a forward annual dividend rate of $4.40. With a payout ratio of 41.3%, this dividend appears highly sustainable, leaving ample room for reinvestment in growth initiatives. National Bank consistently rewards shareholders while maintaining a strong balance sheet. This should give income-focused investors confidence as they look to 2025. Over the past five years, the bank’s average dividend yield has hovered around 3.7%, further cementing its reputation as a reliable dividend stock. From a valuation perspective, National Bank stock is trading at a trailing price-to-earnings (P/E) ratio of 12.5, and a forward P/E of 12.4, thus making it more affordable than some of its larger peers. While not the cheapest on the market, its valuation is reasonable given its growth trajectory, strong profitability, and robust financial health. Its price-to-book ratio of 1.9 remains attractive when compared to its historical averages and suggests that the stock isn’t overpriced at current levels. Looking ahead While National Bank’s fundamentals remain strong, there are areas investors should monitor heading into 2025. The gross impaired loan ratio, which increased to 68 basis points in Q4, is a sign of potential pressure in its credit portfolio. While this remains manageable, it reflects broader economic uncertainties, such as the risk of higher interest rates impacting borrowers. That said, National Bank’s conservative approach to risk management and strong cash reserves, over $163 billion in total cash, position it well to absorb any near-term shocks. Strategically, National Bank has been making moves to expand its presence in wealth management, fintech partnerships, and sustainable finance initiatives. These efforts, paired with the bank’s focus on digital transformation, are expected to support long-term growth. For instance, its investment in advanced technology and mobile banking solutions has allowed it to remain competitive in attracting younger clients while improving operational efficiency. As Canada’s economy continues to recover, these growth strategies should drive value for shareholders in the years ahead. Bottom line National Bank offers a compelling story for investors as we move into 2025. With solid earnings growth, a sustainable dividend, and a reasonable valuation, the stock remains an attractive option for both growth and income-focused investors. Some challenges lie ahead, such as rising impaired loans and margin pressures. Yet the strong capital position, strategic initiatives, and consistent performance provide confidence that it can navigate any economic turbulence. National Bank stands out as a solid Canadian investment poised to hold its own in the financial sector, especially for those seeking stability and income.

Former Prime Minister Manmohan Singh had a special bond with Visakhapatnam and participated in quite a few programmes in the city, including the laying of foundation stone for the expansion of the Visakhapatnam Steel Plant (VSP). He was also instrumental in the expansion of Hindustan Petroleum Corporation Limited (HPCL). There was an air of festivity at the VSP during the visit of Dr. Singh on May 20, 2006. “He laid the foundation stone for expansion of the VSP, besides presenting the PM’s trophy for being the Best Integrated Steel Plant from the same platform. The then CMD, Y. Siva Sagar Rao, received the trophy from Dr. Singh,” recalled a VSP official on Friday. The then Chief Minister, Y.S. Rajasekhara Reddy, the then Union Minister of Steel, Ram Vilas Paswan, and the then MP, T. Subbarami Reddy, were among those present on the occasion. The stone was laid for expansion of the steel plant capacity from 3 million tonnes to 6.3 million tonnes. “Dr. Singh was instrumental in the merger of Hindustan Shipyard Limited (HSL), which was then in losses, with the Defence sector and the Bharat Heavy Plate and Vessels Limited (BHPV) with the Bharat Heavy Electricals Limited (BHEL). He had announced that another shipyard would be allotted to Andhra Pradesh. He had participated in the inaugural of the Gangavaram Port and played a key role in the setting up of the Naval Alternate Operating Base (NAOB) at Rambilli in Visakhapatnam district,” Koyya Prasada Reddy, former Chairman of AP Technology Services (APTS), told The Hindu . Dr. Singh, who was the chief guest at the five-day Indian Science Congress, organised by the Indian Science Congress Association (ISCA) at Andhra University in January 2008, had announced a new scheme – INSPIRE – to attract talent. Dr. Singh had launched INS Arihant, the nuclear-powered submarine, which was built at the Hindustan Shipyard Limited (HSL), on July 26, 2009, the anniversary of ‘Kargil Vijay Diwas’, organised to mark the victory of India over Pakistan in the Kargil War. He had asked his wife Gursharan Kaur to break the coconut to mark the launch of the submarine. Meanwhile, leaders of political parties and others from various walks of life condoled the demise of Dr. Singh. YSRCP MLC Botcha Satyanarayana paid tributes to Dr. Singh in the city. Former Minister Gudivada Amarnath garlanded the portrait of Dr. Singh at the party office. Rajya Sabha member Golla Babu Rao, MLC Varudu Kalyani, party leaders T. Vijay Kumar, T. Nagireddy and Chintalapudi Venkataramaiah paid tributes to the departed leader. Published - December 28, 2024 02:40 am IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit Andhra Pradesh / politics / Indian National CongressNo. 12 Boise State heads to Wyoming hoping to maintain No. 4 seed in College Football Playoff

NoneDrones for commercial and recreational use have grown rapidly in popularity, despite restrictions on who can operate them and where they can be flown. No-fly zones are enforced around airports, military installations, nuclear plants, certain landmarks including the Statue of Liberty, and sports stadiums during games. Not everybody follows the rules. Sightings at airports have shut down flights in a few instances. Reported sightings of what appear to be drones flying over New Jersey at night in recent weeks have created anxiety among some residents, in part because it is not clear who is operating them or why. Some state and local officials have called for stricter rules to govern drones. After receiving reports of drone activity last month near Morris County, New Jersey, the Federal Aviation Administration issued temporary bans on drone flights over a golf course in Bedminster , New Jersey, that is owned by President-elect Donald Trump, and over Picatinny Arsenal Military Base . The FAA says the bans are in response to requests from “federal security partners.” The FAA is responsible for the regulations governing their use , and Congress has written some requirements into law. With a 2018 law, the Preventing Emerging Threats Act, Congress gave certain agencies in the Homeland Security and Justice departments authority to counter threats from unmanned aircraft to protect the safety of certain facilities. New drones must be outfitted with equipment allowing law enforcement to identify the operator, and Congress gave the agencies the power to detect and take down unmanned aircraft that they consider dangerous. The law spells out where the counter-drone measures can be used, including “national special security events” such as presidential inaugurations and other large gatherings of people. To get a “remote pilot certificate,” you must be at least 16 years old, be proficient in English, pass an aeronautics exam, and not suffer from a ”mental condition that would interfere with the safe operation of a small unmanned aircraft system.” Yes, but the FAA imposes restrictions on nighttime operations. Most drones are not allowed to fly at night unless they are equipped with anti-collision lights that are visible for at least 3 miles (4.8 kilometers). Over the past decade, pilots have reported hundreds of close calls between drones and airplanes including airline jets. In some cases, airplane pilots have had to take evasive action to avoid collisions. Drones buzzing over a runway caused flights to be stopped at London’s Gatwick Airport during the Christmas travel rush in 2018 and again in May 2023 . Police dismissed the idea of shooting down the drones, fearing that stray bullets could kill someone. Advances in drone technology have made it harder for law enforcement to find rogue drone operators — bigger drones in particular have more range and power. Some state and local officials in New Jersey are calling for stronger restrictions because of the recent sightings, and that has the drone industry worried. Scott Shtofman, director of government affairs at the Association for Uncrewed Vehicle Systems International, said putting more limits on drones could have a “chilling effect” on “a growing economic engine for the United States.” “We would definitely oppose anything that is blindly pushing for new regulation of what are right now legal drone operations,” he said. AirSight, a company that sells software against “drone threats,” says more than 20 states have enacted laws against privacy invasion by drones, including Peeping Toms. Will Austin, president of Warren County Community College in New Jersey, and founder of its drone program, says it's up to users to reduce public concern about the machines. He said operators must explain why they are flying when confronted by people worried about privacy or safety. “It's a brand new technology that's not really understood real well, so it will raise fear and anxiety in a lot of people,” Austin said. “We want to be good professional aviators and alleviate that.” Associated Press reporter Rebecca Santana in Washington, D.C., contributed.Seattle Seahawks receiver is DK Metcalf is just fine when he doesn't have the the ball because it means he gets to showcase his blocking skills. “I just look at it as a sign of respect that I’ve gained from other defensive coordinators and just continue to do my job with it as blocking or being a decoy,” the two-time Pro Bowler said. While opposing defenses have keyed in on Metcalf, other aspects of Seattle's offense have surfaced during its four-game winning streak. The run has the Seahawks (8-5) sitting atop the NFC West heading into Sunday night's game against the visiting Green Bay Packers (9-4). Geno Smith's new top target is second-year receiver Jaxon Smith-Njigba, who needs 89 receiving yards for his first career 1,000-yard season. Smith-Njigba has 75 catches for 911 yards and five touchdowns, while Metcalf, often dealing with double coverage, has 54 catches for 812 yards and two scores. Metcalf says he feels the pride of a “proud parent or a big brother” when it comes to Smith-Njigba's success. Seattle's offense also got a boost from the ground game in a 30-18 victory over the Arizona Cardinals last weekend . Zach Charbonnet, filling in for the injured Kenneth Walker III, ran for a career-best 134 yards and two touchdowns. The Seahawks face another hot team in the Packers (9-4), who have won seven of nine. Green Bay's two losses over that stretch have come against NFC-best Detroit (12-1), including a 34-31 victory by the Lions on Dec. 5, which means the NFC North title is likely out of reach for the Packers. The Packers are well-positioned for a playoff berth, but that almost certainly won't come this weekend. They would need a win, a loss or tie by the Atlanta Falcons and a tie between the Los Angeles Rams and San Francisco 49ers. Metcalf, who learned to block from his father, former Chicago Bears offensive lineman Terrence Metcalf, says he tries to take blocking seriously to set himself apart from other receivers. His priorities are simple when he's getting double-teamed and the ball goes elsewhere. “Trying to block my (butt) off and trying to get pancakes on defensive backs,” he said. When the Packers surged their way into the playoffs last season, quarterback Jordan Love was a major reason why. He had 18 touchdown passes and one interception during Green Bay's final eight games. During the last four games of this season, Love ranks third in the NFL with a 118.9 passer rating with six touchdowns, one interception and a league-best 10.3 yards per attempt. “I always feel like I can put the ball where I want to — and that’s part of it, too, having that confidence to be able to throw those passes,” Love said. “There’s always like I said a handful of plays that might not come off or be in the exact spot that you wanted it to or the throw might be a little bit off. So, that’s where you’ve just got to try to be at your best every play, be consistent and accurate as possible.” Green Bay’s pass defense has been picked apart the last two weeks. First, it was torched by Tua Tagovailoa and the Dolphins in a Packers win. Next, it allowed Jared Goff to complete his final 13 passes as the Lions rallied to victory. It won’t get any easier this week. Smith is second in the NFL in attempts, completions and passing yards and is fifth in completion percentage. “It’s been a remarkable turnaround for him in terms of just where he started,” Packers coach Matt LaFleur said. “It’s not always where you start, but where you finish. And it tells me a lot about the person in terms of his resiliency and ability to fight through some adversity. He’s a dangerous quarterback.” The potential return of former All-Pro cornerback Jaire Alexander (knee) could help the Packers. Will the Packers break out their head-to-toe white uniforms? The last time Green Bay wore the winter white look was in a 24-22 win over Houston in October. The Packers asked fans to weigh in on social media . As for the Seahawks, they'll be sporting their “Action Green” uniforms. Metcalf is a fan. “I would say this about the Action Green, I love them personally in my opinion, but the big guys hate them. I don’t know why, don’t ask me," he said. “Hopefully, the Packers wear all white, so it’ll be a fun-looking game.” AP NFL: https://apnews.com/hub/nfl

Drones for commercial and recreational use have grown rapidly in popularity, despite restrictions on who can operate them and where they can be flown. No-fly zones are enforced around airports, military installations, nuclear plants, certain landmarks including the Statue of Liberty, and sports stadiums during games. Not everybody follows the rules. Sightings at airports have shut down flights in a few instances. Reported sightings of what appear to be drones flying over New Jersey at night in recent weeks have created anxiety among some residents, in part because it is not clear who is operating them or why. Some state and local officials have called for stricter rules to govern drones. After receiving reports of drone activity last month near Morris County, New Jersey, the Federal Aviation Administration issued temporary bans on drone flights over a golf course in Bedminster , New Jersey, that is owned by President-elect Donald Trump, and over Picatinny Arsenal Military Base . The FAA says the bans are in response to requests from “federal security partners.” The FAA is responsible for the regulations governing their use , and Congress has written some requirements into law. With a 2018 law, the Preventing Emerging Threats Act, Congress gave certain agencies in the Homeland Security and Justice departments authority to counter threats from unmanned aircraft to protect the safety of certain facilities. New drones must be outfitted with equipment allowing law enforcement to identify the operator, and Congress gave the agencies the power to detect and take down unmanned aircraft that they consider dangerous. The law spells out where the counter-drone measures can be used, including “national special security events” such as presidential inaugurations and other large gatherings of people. To get a “remote pilot certificate,” you must be at least 16 years old, be proficient in English, pass an aeronautics exam, and not suffer from a ”mental condition that would interfere with the safe operation of a small unmanned aircraft system.” Yes, but the FAA imposes restrictions on nighttime operations. Most drones are not allowed to fly at night unless they are equipped with anti-collision lights that are visible for at least 3 miles (4.8 kilometers). Over the past decade, pilots have reported hundreds of close calls between drones and airplanes including airline jets. In some cases, airplane pilots have had to take evasive action to avoid collisions. Drones buzzing over a runway caused flights to be stopped at London’s Gatwick Airport during the Christmas travel rush in 2018 and again in May 2023 . Police dismissed the idea of shooting down the drones, fearing that stray bullets could kill someone. Advances in drone technology have made it harder for law enforcement to find rogue drone operators — bigger drones in particular have more range and power. Some state and local officials in New Jersey are calling for stronger restrictions because of the recent sightings, and that has the drone industry worried. Scott Shtofman, director of government affairs at the Association for Uncrewed Vehicle Systems International, said putting more limits on drones could have a “chilling effect” on “a growing economic engine for the United States.” “We would definitely oppose anything that is blindly pushing for new regulation of what are right now legal drone operations,” he said. AirSight, a company that sells software against “drone threats,” says more than 20 states have enacted laws against privacy invasion by drones, including Peeping Toms. Will Austin, president of Warren County Community College in New Jersey, and founder of its drone program, says it's up to users to reduce public concern about the machines. He said operators must explain why they are flying when confronted by people worried about privacy or safety. “It's a brand new technology that's not really understood real well, so it will raise fear and anxiety in a lot of people,” Austin said. “We want to be good professional aviators and alleviate that.” Associated Press reporter Rebecca Santana in Washington, D.C., contributed.Wain Homes SW Ltd has completed the acquisition of land at Dudman Farm in Truro to deliver 274 energy efficient new homes. Dudman Farm sits to the south west of Truro City Centre, bordering onto open countryside and benefits from panoramic views. Situated in close proximity to the Royal Cornwall (Trelikse) Hospital, the proposed scheme will deliver a wide range of one to four-bedroom homes set in two distinct east and west areas divided by a picturesque valley. Construction work is set to start this month (November) with more than one third (90 homes) of the development designated as affordable. As part of the development agreement for Dudman Farm, Wain Homes will contribute £2.3m to the local community through education, health and transport provisions. Wain Homes is also providing above policy quantum levels of open space for people to enjoy the spectacular landscape. Mark Harding, land and planning director for Wain Homes, said: “Dudman Farm will be Wain Homes’ first development in Truro since 2013 and is an incredibly important land acquisition for the company. It will give us a very strong foothold in a prime market in Truro and demonstrates our commitment to significantly increasing the number of homes we will be providing in the South West over the coming years. “We have been working closely with our consultant team on Dudman Farm and I am appreciative of everyone’s dedication and hard work. Due to its topography, the development has been a complicated project and I am pleased the social and economic benefits of the scheme have been realised, enabling us to make a significant contribution to desired housing supply.”

DK Metcalf is happy to block as Seahawks ride streak into Sunday night matchup with Packers